Generally, a “Strong Buy” rating on Wall Street indicates that analysts believe the stock will appreciate and outperform the broader market and its industry peers. It also expresses analysts’ belief in the company’s fundamentals, industry or growth prospects, industry trends, competitive advantages, or macroeconomic conditions.
Here are two biotech stocks that Wall Street is very bullish on. Let’s find out why.
